Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
M. Agulnik, E. Cohen, R. Cohen, et al.. (2007). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Cited 239 times. https://doi.org/10.1200/JCO.2007.11.8612
Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma